High throughput screening in drug discovery
- PMID: 16870538
- DOI: 10.1007/s12094-006-0048-2
High throughput screening in drug discovery
Abstract
Drug discovery is a highly complex and multidisciplinary process which goal is to identify new antitumoral drugs. The screening attrition rate in the current drug discovery protocols suggests that one marketable drug emerges from approximately one million screened compounds. This leads to pressure to screen larger libraries in order to continue the pipeline and to the development of High Throughput Screening. HTS is only a name for specific developments in laboratory automation to collect a large amount of experimental data in a relatively short time. HTS can test hundreds of thousands of compounds per day, however, if fewer compounds could be tested without compromising the probability of success, the cost and time would be greatly reduced. To that end, new developments in large-scale cell biology and compound library design in silico have evolved to obtain data with higher predictability of clinical efficacy.
Similar articles
-
High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases.Bioengineering (Basel). 2021 Feb 23;8(2):30. doi: 10.3390/bioengineering8020030. Bioengineering (Basel). 2021. PMID: 33672148 Free PMC article. Review.
-
Technological advances in high-throughput screening.Am J Pharmacogenomics. 2004;4(4):263-76. doi: 10.2165/00129785-200404040-00006. Am J Pharmacogenomics. 2004. PMID: 15287820 Review.
-
Streamlining lead discovery by aligning in silico and high-throughput screening.Curr Opin Chem Biol. 2006 Aug;10(4):343-51. doi: 10.1016/j.cbpa.2006.06.022. Epub 2006 Jul 5. Curr Opin Chem Biol. 2006. PMID: 16822701 Review.
-
Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective.Pharm Res. 1997 Nov;14(11):1504-10. doi: 10.1023/a:1012105713585. Pharm Res. 1997. PMID: 9434267 Review.
-
The multicellular tumor spheroid model for high-throughput cancer drug discovery.Expert Opin Drug Discov. 2012 Sep;7(9):819-30. doi: 10.1517/17460441.2012.708334. Epub 2012 Jul 12. Expert Opin Drug Discov. 2012. PMID: 22788761 Review.
Cited by
-
Advances in coamorphous drug delivery systems.Acta Pharm Sin B. 2019 Jan;9(1):19-35. doi: 10.1016/j.apsb.2018.08.002. Epub 2018 Aug 16. Acta Pharm Sin B. 2019. PMID: 30766775 Free PMC article.
-
Matching the power of high throughput screening to the chemical diversity of natural products.Nat Prod Rep. 2013 Oct 11;30(10):1284-98. doi: 10.1039/c3np70052f. Epub 2013 Aug 8. Nat Prod Rep. 2013. PMID: 23925671 Free PMC article. Review.
-
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype.J Vis Exp. 2022 Jun 17;(184):10.3791/63383. doi: 10.3791/63383. J Vis Exp. 2022. PMID: 35786700 Free PMC article.
-
Automated measurement of fast mitochondrial transport in neurons.Front Cell Neurosci. 2015 Nov 3;9:435. doi: 10.3389/fncel.2015.00435. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26578890 Free PMC article.
-
Photochemical C-H arylation of heteroarenes for DNA-encoded library synthesis.Chem Sci. 2021 Dec 21;13(4):1023-1029. doi: 10.1039/d1sc05683b. eCollection 2022 Jan 26. Chem Sci. 2021. PMID: 35211268 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources